Free Trial

Phibro Animal Health (PAHC) Competitors

Phibro Animal Health logo
$27.99 +0.05 (+0.18%)
Closing price 07/3/2025 03:54 PM Eastern
Extended Trading
$27.94 -0.04 (-0.16%)
As of 07/3/2025 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PAHC vs. KRYS, RYTM, CYTK, PTCT, ZLAB, ACAD, MRUS, ACLX, SWTX, and RNA

Should you be buying Phibro Animal Health stock or one of its competitors? The main competitors of Phibro Animal Health include Krystal Biotech (KRYS), Rhythm Pharmaceuticals (RYTM), Cytokinetics (CYTK), PTC Therapeutics (PTCT), Zai Lab (ZLAB), ACADIA Pharmaceuticals (ACAD), Merus (MRUS), Arcellx (ACLX), SpringWorks Therapeutics (SWTX), and Avidity Biosciences (RNA). These companies are all part of the "pharmaceutical products" industry.

Phibro Animal Health vs. Its Competitors

Phibro Animal Health (NASDAQ:PAHC) and Krystal Biotech (NASDAQ:KRYS) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, dividends, institutional ownership, earnings, valuation and analyst recommendations.

Phibro Animal Health presently has a consensus price target of $21.80, suggesting a potential downside of 22.12%. Krystal Biotech has a consensus price target of $211.13, suggesting a potential upside of 47.63%. Given Krystal Biotech's stronger consensus rating and higher probable upside, analysts clearly believe Krystal Biotech is more favorable than Phibro Animal Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Phibro Animal Health
2 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67
Krystal Biotech
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.00

99.3% of Phibro Animal Health shares are held by institutional investors. Comparatively, 86.3% of Krystal Biotech shares are held by institutional investors. 50.1% of Phibro Animal Health shares are held by insiders. Comparatively, 13.7% of Krystal Biotech shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Krystal Biotech had 12 more articles in the media than Phibro Animal Health. MarketBeat recorded 17 mentions for Krystal Biotech and 5 mentions for Phibro Animal Health. Phibro Animal Health's average media sentiment score of 0.25 beat Krystal Biotech's score of 0.01 indicating that Phibro Animal Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Phibro Animal Health
0 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Krystal Biotech
4 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Krystal Biotech has a net margin of 37.17% compared to Phibro Animal Health's net margin of 2.68%. Phibro Animal Health's return on equity of 30.51% beat Krystal Biotech's return on equity.

Company Net Margins Return on Equity Return on Assets
Phibro Animal Health2.68% 30.51% 6.89%
Krystal Biotech 37.17%14.64%13.28%

Krystal Biotech has lower revenue, but higher earnings than Phibro Animal Health. Krystal Biotech is trading at a lower price-to-earnings ratio than Phibro Animal Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Phibro Animal Health$1.02B1.11$2.42M$0.7835.88
Krystal Biotech$290.52M14.23$89.16M$4.1634.38

Phibro Animal Health has a beta of 0.75, suggesting that its share price is 25% less volatile than the S&P 500. Comparatively, Krystal Biotech has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500.

Summary

Krystal Biotech beats Phibro Animal Health on 10 of the 17 factors compared between the two stocks.

Get Phibro Animal Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for PAHC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PAHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PAHC vs. The Competition

MetricPhibro Animal HealthMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.13B$10.52B$5.56B$9.04B
Dividend Yield1.71%2.07%5.24%4.01%
P/E Ratio35.8917.0327.6620.25
Price / Sales1.1129.59415.10118.18
Price / Cash13.2522.9936.8958.07
Price / Book4.413.668.035.67
Net Income$2.42M$235.40M$3.18B$249.21M
7 Day Performance9.08%2.15%2.93%3.27%
1 Month Performance17.16%3.38%3.75%5.55%
1 Year Performance66.11%-10.18%35.16%21.08%

Phibro Animal Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PAHC
Phibro Animal Health
3.6484 of 5 stars
$27.99
+0.2%
$21.80
-22.1%
+63.3%$1.13B$1.19B35.891,860
KRYS
Krystal Biotech
4.5851 of 5 stars
$137.46
-1.0%
$211.13
+53.6%
-19.5%$4.01B$290.52M33.04210News Coverage
Analyst Revision
RYTM
Rhythm Pharmaceuticals
3.8158 of 5 stars
$63.19
+0.7%
$77.31
+22.3%
+61.2%$3.99B$130.13M-22.49140News Coverage
CYTK
Cytokinetics
3.9341 of 5 stars
$33.04
-0.4%
$70.92
+114.7%
-37.7%$3.96B$18.47M-6.25250
PTCT
PTC Therapeutics
4.3225 of 5 stars
$48.84
-2.0%
$65.00
+33.1%
+57.3%$3.95B$806.78M7.501,410Analyst Revision
ZLAB
Zai Lab
3.4348 of 5 stars
$34.97
+0.7%
$54.28
+55.2%
+111.6%$3.86B$398.99M-14.041,869News Coverage
Insider Trade
Analyst Revision
Gap Up
ACAD
ACADIA Pharmaceuticals
4.624 of 5 stars
$21.57
-2.5%
$27.88
+29.2%
+34.4%$3.70B$957.80M15.74510
MRUS
Merus
1.8603 of 5 stars
$52.60
-0.7%
$84.64
+60.9%
+1.7%$3.67B$36.13M-12.8937
ACLX
Arcellx
2.9577 of 5 stars
$65.85
+0.8%
$111.23
+68.9%
+23.0%$3.60B$107.94M-22.0280
SWTX
SpringWorks Therapeutics
1.3783 of 5 stars
$46.99
+0.0%
$52.57
+11.9%
N/A$3.54B$191.59M-13.78230Positive News
RNA
Avidity Biosciences
1.8242 of 5 stars
$28.40
-2.2%
$65.59
+130.9%
-21.7%$3.50B$10.90M-9.47190

Related Companies and Tools


This page (NASDAQ:PAHC) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners